Isoniazid or Rifampicin and Isoniazid Preventive Therapy for children exposed to TB - the IRIPT trial
Not Applicable
- Conditions
- TuberculosisPaediatrics
- Registration Number
- PACTR201101000273931
- Lead Sponsor
- Christian Wejse
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Other
- Sex
- All
- Target Recruitment
- 880
Inclusion Criteria
1)Household contact of TB case
2)Age<5 years or
age 5-14 years + a positive TST (>5mm)
3)Informed consent given by parent or person in loco parentis
Exclusion Criteria
1)Active TB at time of inclusion
2)HIV-positive child receiving HAART
3)Known liver disease or allergy to INH or RIF
4)Pregnancy (all girls>12 years will get a pregnancy test)
5)A history of seizures
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method